Xilong Scientific Co., Ltd. (SHE:002584)

Xilong Scientific Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	7,136	7,803	7,078	6,176	5,372	6,235
Other Revenue	13.86	13.86	13.73	7.27	8.12	8.18
Revenue	7,150	7,816	7,092	6,183	5,380	6,243
Revenue Growth (YoY)	-1.94%	10.22%	14.69%	14.93%	-13.83%	87.05%
Cost of Revenue	6,635	7,294	6,632	5,756	4,856	5,787
Gross Profit	514.92	522.88	459.7	426.78	523.64	456.34
Selling, General & Admin	254.38	243.65	234.82	211.47	240.76	251.47
Research & Development	94.41	109.9	95.7	90.47	118.97	102.72
Other Operating Expenses	4.21	-3.54	5.75	17.19	16.02	14.08
Operating Expenses	374.79	361.49	344.61	331.92	395.75	381.31
Operating Income	140.12	161.39	115.1	94.86	127.88	75.04
Interest Expense	-46.44	-46.21	-60.86	-49.08	-67.5	-65.09
Interest & Investment Income	6.82	5.38	6.7	92.1	144.18	12.52
Currency Exchange Gain (Loss)	-3.25	-3.25	-4.38	-9.5	1.3	17.89
Other Non Operating Income (Expenses)	-139.22	-28.17	-13.96	-29.59	-7.76	-3.56
EBT Excluding Unusual Items	-46.36	89.15	42.6	98.79	198.11	36.79
Impairment of Goodwill	-	-	-6.54	-	-	-11.95
Gain (Loss) on Sale of Investments	0.25	0.02	-	0	-	-0.36
Gain (Loss) on Sale of Assets	-0.85	-0.84	0.21	-0.14	-0.39	43.94
Asset Writedown	-4.61	-6.32	-0.5	-1.47	0.34	-0.66
Other Unusual Items	-7.14	-9.72	7.15	5.57	11.04	13.49
Pretax Income	-58.71	72.29	42.92	102.74	209.1	81.25
Income Tax Expense	4.24	9.3	8.33	15.04	7.98	17.56
Earnings From Continuing Operations	-62.96	62.99	34.59	87.69	201.12	63.69
Minority Interest in Earnings	-1.29	-1.22	-1.24	1.37	-14.06	-6.81
Net Income	-64.24	61.77	33.35	89.06	187.06	56.87
Net Income to Common	-64.24	61.77	33.35	89.06	187.06	56.87
Net Income Growth	-	85.24%	-62.56%	-52.39%	228.91%	47.62%
Shares Outstanding (Basic)	561	562	556	594	534	569
Shares Outstanding (Diluted)	561	562	556	594	534	569
Shares Change (YoY)	1.68%	1.04%	-6.39%	11.09%	-6.02%	3.33%
EPS (Basic)	-0.11	0.11	0.06	0.15	0.35	0.10
EPS (Diluted)	-0.11	0.11	0.06	0.15	0.35	0.10
EPS Growth	-	83.33%	-60.00%	-57.14%	250.00%	42.86%
Free Cash Flow	374.57	257.23	-499.96	-514.59	316.27	6.33
Free Cash Flow Per Share	0.67	0.46	-0.90	-0.87	0.59	0.01
Dividend Per Share	-	0.033	0.020	-	-	-
Dividend Growth	-	65.00%	-	-	-	-
Gross Margin	7.20%	6.69%	6.48%	6.90%	9.73%	7.31%
Operating Margin	1.96%	2.07%	1.62%	1.53%	2.38%	1.20%
Profit Margin	-0.90%	0.79%	0.47%	1.44%	3.48%	0.91%
Free Cash Flow Margin	5.24%	3.29%	-7.05%	-8.32%	5.88%	0.10%
EBITDA	183.47	203.36	155.22	130.97	157.56	104.93
EBITDA Margin	2.57%	2.60%	2.19%	2.12%	2.93%	1.68%
D&A For EBITDA	43.35	41.97	40.13	36.11	29.68	29.9
EBIT	140.12	161.39	115.1	94.86	127.88	75.04
EBIT Margin	1.96%	2.07%	1.62%	1.53%	2.38%	1.20%
Effective Tax Rate	-	12.86%	19.41%	14.64%	3.82%	21.61%
Revenue as Reported	7,150	7,816	7,092	6,183	5,380	6,243
Advertising Expenses	-	3.85	0.39	3.73	0.97	0.67

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.